Skip to content

Destiffening and Hypotensive Effects of Whole Milk and Full-fat Dairy Products

Destiffening and Hypotensive Effects of Whole Milk and Full-fat Dairy Products

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02397902
Enrollment
60
Registered
2015-03-25
Start date
2015-03-31
Completion date
2018-01-30
Last updated
2018-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension, Prehypertension

Brief summary

The specific aim of the proposed study is to address the efficacy of conventional full-fat dairy products as part of the normal routine diet for improving vascular function and reducing blood pressure in middle-aged and older adults with elevated blood pressure. The investigators hypothesize that dietary intervention including whole milk and full-fat milk products will induce significant decreases in systolic blood pressure and arterial stiffness. The investigators also test the hypothesis that the reductions in blood pressure will be associated with the corresponding decreases in arterial stiffness and/or increases in endothelial vasodilatory function as well as improvements in arterial baroreflex sensitivity. If our hypotheses are supported by the results, the information could be used as a basis for recommendations for the use of whole milk and full-fat milk products in the secondary prevention of elevated blood pressure and vascular dysfunction.

Interventions

DIETARY_SUPPLEMENTHigh fat dairy

Add 4 daily servings per day of high fat dairy (yogurt, milk, cheese) for a period of 4 weeks

DIETARY_SUPPLEMENTPlant-based

Add 4 daily servings of fruit (fruit cup, apple sauce) and/or plant-based milk, remove all dairy for a period for 4 weeks

Sponsors

Dairy Management Inc.
CollaboratorINDUSTRY
University of Texas at Austin
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Prehypertension or stage-1 hypertension

Exclusion criteria

* Consume \> 3 servings of dairy or fruit per day * Strenuous physical activity \> 3 time per week * Lactose intolerance, pregnancy, lactation, and/or alcohol abuse * Taking cardiovascular-acting drugs * Overt cardiovascular disease, metabolic disease, GI disorders and/or renal disease

Design outcomes

Primary

MeasureTime frame
Seated blood pressure4 weeks

Secondary

MeasureTime frame
24-hour ambulatory blood pressure4 weeks
Carotid arterial compliance as measured by arterial pressure and corresponding cross-sectional area by ultrasound4 weeks
Arterial stiffness as measured by pulse wave velocity between the aortic arch and femoral artery4 weeks
Flow mediated dilation4 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026